10x Genomics, Inc. (TXG) has seen some recent activity in the market and its stock closed at $141.03 yesterday. Traders are starting to take interest of TXG as the stock traded as high as $142.81 and as low as $138.36 in the last market trading day.
10x Genomics, Inc. (TXG) average trading volume is 779.20K. However, in the last market trading day 10x Genomics, Inc. (TXG) traded 333,839 shares. The 1st downside support level on TXG is $130.53 and the 1st resistance level on TXG is $171.13. TXG 50 day moving average is $135.90 and TXG 200 day moving average is $101.05.
10x Genomics, Inc. (TXG) current performance has been indicated by the recent movement in TXG stock. TXG has performed 12.85% over the past 4 weeks, TXG has performed 44.63% over the past quarter and TXG has shown 157.54% over the past 365 days. 10x Genomics, Inc. (TXG) has a 12 month range of $48.78 to $166.31. 10x Genomics, Inc. (TXG) is trading 189.11% from its 12 month low and -15.20% from its 12 month high. 10x Genomics, Inc. (TXG) is showing a 2.79% short float showing the quantity short in the float.
TXG has 98.98M shares outstanding and 67.42M shares in the float. 10x Genomics, Inc. (TXG) at this time has a market cap of $15.05B and income of -78.00M. The EPS next quarter for TXG is -0.31 and forecasted EPS next year is 75.70%. The market cap of 10x Genomics, Inc. (TXG) at $15.05B signifies how many Traders own shares of TXG and is based off the last price ($141.03) of TXG and the quantity of shares outstanding (98.98M) with 10x Genomics, Inc. (TXG).
10x Genomics, Inc. (TXG) has total cash (mrq) of 339.84M, total cash per share (mrq) of 3.39, total debt of TXG is at 59.17M and total debt/equity (mrq) is 15.12. . 10x Genomics, Inc. (TXG) operational cash flow (ttm) is -10.87M, TXG leveraged free cash flow (ttm) is -7.88M.
TXG is trading -3.91% below (bearish) its SMA20, 10.32% above (bullish) its SMA50 and 51.17% above (bullish) its SMA200.